Trademarkia Logo

Canada

C$
Trademark Search in Canada
EPICENTRX

View On IC.GC.CA

EPICENTRX
SEARCHED

on 15 Aug 2023

Last Applicant/ Owned by

EPICENTRX INC.

11099 North Torrey Pines Road,Suite 160La Jolla CA 92037

US

Serial Number

2181936 filed on 22nd Dec 2021

Correspondent Address

OSLER, HOSKIN & HARCOURT LLP

Suite 320, World Exchange Plaza100 Queen StreetOttawa,

ONTARIO

CA

K1P1J9

EPICENTRX

Trademark usage description

pharmaceutical products, preparations, and substances for the prevention and treatment of cancer, infectious diseases, allergies, mental illnesses, ch Read More

Classification Information

Class [005]
Pharmaceutical products, preparations, and substances for the prevention and treatment of cancer, infectious diseases, allergies, mental illnesses, chemotherapy side effects, radiation side effects, transplantation side effects, and viral, metabolic, cardiovascular, vascular, pulmonary, blood, dermatologic, fibrotic, autoimmune, inflammatory, neurodegenerative, neuromuscular, dietary deficiency, hereditary, endocrine, eye, ear, and voice related diseases and disorders; biological products, preparations, and substances for the prevention and treatment of cancer, infectious diseases, allergies, mental illnesses, chemotherapy side effects, radiation side effects, transplantation side effects, and viral, metabolic, cardiovascular, vascular, pulmonary, blood, dermatologic, fibrotic, autoimmune, inflammatory, neurodegenerative, neuromuscular, dietary deficiency, hereditary, endocrine, eye, ear, and voice related diseases and disorders; immunotherapies for the prevention and treatment of cancer, infectious diseases, allergies, mental illnesses, chemotherapy side effects, radiation side effects, transplantation side effects, and viral, metabolic, cardiovascular, vascular, pulmonary, blood, dermatologic, fibrotic, autoimmune, inflammatory, neurodegenerative, neuromuscular, dietary deficiency, hereditary, endocrine, eye, ear, and voice related diseases and disorders; vaccines; biotechnology platform technology, namely, viral and vaccine vectors for delivery and insertion of function-altering genetic material into human and animal patients, plants, and crops, for visualization of specific cell types, for inducing humoral and cell-mediated responses, for targeting and killing cancer cells, for removing pathological functions, for controlling biological pests, and for boosting crop yields; chemical platform technology, namely, small molecule compounds for inducing the expression of antioxidant, anti-inflammatory, and cytoprotective proteins in non-malignant tissues, for activating the immune system, for modulating blood flow in ischemic tissues, for upregulating proinflammatory mediators in tumors, and for treating plant diseases.

Classification kind code

11

Class [042]
Scientific and medical research and development in the fields of pharmaceuticals, biologics, agriculture, pest control, biotechnology, immunotherapies, and vaccines.

Classification kind code

11

Mark Details

Serial Number

2181936

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 48
on 22nd Dec 2023		Agent Changed
Submitted for opposition 22
on 15th Aug 2023		Search Recorded
Submitted for opposition 20
on 15th Aug 2023		Examiner's First Report
Submitted for opposition 223
on 15th Aug 2023		Total Provisional Refusal
Submitted for opposition 256
on 28th Feb 2023		Notification of Possible Opposition Sent
Submitted for opposition 257
on 28th Apr 2022		Designation Notification - Madrid Protocol
Submitted for opposition 31
on 27th Apr 2022		Formalized
Submitted for opposition 1
on 27th Apr 2022		Created
Submitted for opposition 228
on 22nd Dec 2021		International Registration
Submitted for opposition 30
on 22nd Dec 2021		Filed